Substance Details ADB-BUTINACA

ADB-BUTINACA

Names:	ADB-BUTINACA N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide, N-[1-(Aminocarbonyl)-2,2-dimethylpropyl]-1-butyl-1H-indazole-3-carboxamide MMBA(N)-073
IUPAC name:	N-[1-(Aminocarbonyl)-2,2-dimethylpropyl]-1-butyl-1H-indazole-3-carboxamide
Substance group:	Synthetic cannabinoids
Effect group:	Synthetic cannabinoid receptor agonists
Structure:
CAS Number:	2666932-43-8
InChI:	InChI=1S/C18H26N4O2/c1-5-6-11-22-13-10-8-7-9-12(13)14(21-22)17(24)20-15(16(19)23)18(2,3)4/h7-10,15H,5-6,11H2,1-4H3,(H2,19,23)(H,20,24)
InChI Key:	GPWADXHYJAZPAX-UHFFFAOYSA-N
SMILES:	CCCCn2nc(C(=O)NC(C(N)=O)C(C)(C)C)c1ccccc12
Molecular Formula:	C₁₈H₂₆N₄O₂
Molecular Weight:	330.4247 g/mol
Control status:	71/II
Year of scheduling:	2023
Description:	The name ADB-BINACA has been used to refer to ADB-BUTINACA (N-[1-amino-3,3-dimethyl-1oxobutan-2-yl]-1-butyl-1H-indazole-3-carboxamide), the analogue with the 1-butyl substituent on the indazole ring instead of the 1-benzyl substituent. ADB-BINACA is the name used for the analogue with the benzyl substituent on the indazole ring as the tail portion (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-benzyl-1H-indazole-3-carboxamide), while ADB-BUTINACA contains a butyl moiety as its tail. https://cdn.who.int/media/docs/default-source/controlled-substances/45th-ecdd/adb-butinaca_draft.pdf?sfvrsn=89c83ba5_1 Please note this when interpreting trend data due to variable reporting practices which are currently under review.